Danaher Corporation (BVMF:DHER34)

Market Cap	799.22B -23.9%
Revenue (ttm)	135.32B +2.9%
Net Income	19.91B -7.3%
EPS	27.81 -4.5%
Shares Out	n/a
PE Ratio	40.15
Forward PE	25.42
Dividend	0.17 (0.42%)
Ex-Dividend Date	Dec 23, 2025

Volume	11
Average Volume	3,611
Open	40.40
Previous Close	40.49
Day's Range	40.16 - 40.48
52-Week Range	33.66 - 46.06
Beta	0.96
RSI	37.46
Earnings Date	Jan 28, 2026

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1969
• Employees: 60,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: DHER34

Financial Performance

In 2025, Danaher's revenue was $24.57 billion, an increase of 2.90% compared to the previous year's $23.88 billion. Earnings were $3.61 billion, a decrease of -7.31%.

Financial numbers in USD